NCT04065074View on ClinicalTrials.gov

Study to Evaluate a Procedure for Intra-articular Injection of FX006 in Patients With Osteoarthritis of the Hip

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 30, 2019

Primary Completion Date

October 11, 2019

Study Completion Date

December 30, 2019

Conditions
Osteoarthritis, Hip
Interventions
DRUG

FX006 32 mg

Extended-release 32 mg FX006 IA injection

Trial Locations (5)

10075

Lenox Hill Hospital, New York

85704

Noble Clinical Research, Tucson

91303

Hope Clinical Research, Canoga Park

91767

Dream Team Clinical Research, Pomona

91942

Biosolutions Clinical Research Center, La Mesa

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY